olopatadine hydrochloride 0.1% ophthalmic solution

DRUG3 trials

Sponsors

Alcon Research, Allergan, Santen Pharmaceutical Co., Ltd.

Conditions

Allergic ConjunctivitisConjunctivitis, AllergicRhinitis, Allergic, Seasonal

Phase 3

Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis

CompletedNCT01258309

AllerganConjunctivitis, Allergic, Rhinitis, Allergic, Seasonal

Start: 2010-12-31End: 2011-01-31Updated: 2012-01-25

Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

CompletedNCT01363700

Santen Pharmaceutical Co., Ltd.Allergic Conjunctivitis

Updated: 2014-11-19

Phase 4

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

CompletedNCT01119287

Alcon ResearchAllergic Conjunctivitis

Start: 2010-03-31End: 2010-09-30Updated: 2014-02-28

Related Papers

Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.

2014-08-2016 citations